Find an expert
Our panel of editors are available for interview
Dr Brandy Shillace
Editor-in-Chief of Medical Humanities
Brandy Schillace, PhD, is Senior Research Associate and Public Engagement and Programs Leader for the Dittrick Museum of Medical History. Dr Schillace writes about intersections of medicine, history, and literature. For ten years, she managed the medical anthropology journal, Culture, Medicine and Psychiatry, and edited its first medical humanities special issue. Brandy’s recent books include Death’s Summer Coat (2016), Clockwork Futures (2017) and Mr Humble and Dr Butcher: A Monkey’s Head, the Pope’s Neuroscientist, and the Quest to Transplant the Soul (2021).
Dr James Mountford
Editor-in-Chief of BMJ Leader
Dr James Mountford is Director of Quality at Royal Free London NHS Foundation Trust. He worked initially as an NHS doctor, then in consulting. From 2005-2007, he was a Commonwealth Fund Health Foundation Harkness Fellow based in Massachusetts General Hospital, and at the Institute for Healthcare Improvement (IHI), both in Boston, USA. Before moving to the Royal Free, he was Director of Quality at UCL Partners, an academic health sciences partnership serving a population of 3 million in and around London. He sits on the board of AQuA, the improvement partnership based in north-west England. In March 2020 he was seconded to work as the Chief of Quality and Learning at the NHS Nightingale Hospital London, opened in response to the COVID-19 pandemic.
Professor Bryony Dean Franklin
Editor-in-Chief of BMJ Quality & Safety
Professor Bryony Dean Franklin is a hospital pharmacist by background, with 30 years’ experience of research into medication safety, medication use in practice and patient safety more generally. She is Co-Editor-in-Chief of BMJ Quality & Safety, Professor of Medication Safety at UCL School of Pharmacy, Executive Lead Pharmacist for Research at Imperial College Healthcare NHS Trust, Director of the NIHR North West London Patient Safety Research Collaboration and theme lead for the NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London. Professor Franklin has published widely on medication safety, the evaluation of various technologies designed to reduce errors, and the patient’s role in patient safety. Her current post combines research, quality improvement, education and training, medical publishing and hospital pharmacy practice.
Dr Nick Brown
Editor-in-Chief of Archives of Disease in Childhood
Dr Nick Brown is a paediatrician and epidemiologist. His initial training was in the UK in general paediatrics, but for the last 25 years, he has had a parallel carer in academic international child health. Nick has lived and worked in Sudan, Afghanistan, Papua New Guinea, India and Pakistan, largely as an epidemiologist. He has a long affiliation with the Aga Khan University in Karachi where he teaches epidemiology, biostatistics and research methodology and is involved in studies in child pneumonia, rheumatic heart disease, thalassaemia and early child development. Nick is currently based in Sweden with a clinical position in Gavle and academic affiliation with the International Centre for Maternal and Child Health at Uppsala University.
Dr Ellen Weber
Editor-in-Chief of Emergency Medicine Journal
Dr Ellen Weber is an emergency medicine physician in San Francisco, California. She received her medical degree from Harvard Medical School and has been in practice for more than 20 years. She has worked clinically in community, county and academic emergency departments, and conducts research in topics related to health policy. She is currently a Professor of Emergency Medicine and Vice Chair at UCSF.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
